Case Details
- Citation: [2016] SGHC 21
- Title: Hii Chii Kok v Ooi Peng Jin London Lucien and another
- Court: High Court of the Republic of Singapore
- Date: 22 February 2016
- Judge: Chan Seng Onn J
- Suit No: Suit No 806 of 2012
- Hearing Dates: 23, 29, 30 April; 6–9 May; 30 September; 1–3, 28–31 October 2014; 25–27 August; 2–4, 8–9, 14–16 September; 27 November 2015
- Plaintiff/Applicant: Hii Chii Kok
- Defendants/Respondents: Ooi Peng Jin London Lucien and another
- Second Defendant (as described in the judgment): National Cancer Centre of Singapore Pte Ltd (“NCCS”)
- Legal Area: Tort — Negligence (medical negligence)
- Core Sub-issues: Breach of duty; causation
- Statutes Referenced: Not stated in the provided extract
- Cases Cited (as provided): [2011] SGHC 193; [2016] SGHC 21
- Judgment Length: 123 pages; 37,455 words
Summary
Hii Chii Kok v Ooi Peng Jin London Lucien and another ([2016] SGHC 21) is a medical negligence case arising from the diagnosis and management of a patient with suspected pancreatic neuroendocrine tumours (“PNETs”). The plaintiff, a Malaysian businessman, underwent extensive investigations after imaging suggested high tracer uptake in two pancreatic locations. Clinicians at the National Cancer Centre of Singapore (“NCCS”), including the first defendant surgeon, advised that the lesions could be surgically removed and that post-operative histopathology would be the most definitive way to distinguish PNETs from a rarer, less serious condition—pancreatic polypeptide hyperplasia (“hyperplasia”).
After the plaintiff elected “aggressive treatment” and proceeded with a Whipple procedure and related pancreatic surgery, post-operative histopathology revealed that he had hyperplasia rather than PNETs. He then sued the surgeon and NCCS for negligence in relation to (i) the diagnoses and (ii) the advice and post-operative management. Applying Singapore’s established medical negligence framework derived from Khoo James and the Bolam–Bolitho test, the High Court held that the defendants were not negligent in reaching the diagnoses, advising the plaintiff, or managing him after surgery. Even if the court applied the more patient-centric informed consent approach associated with Montgomery v Lanarkshire Health Board, the court found no negligence on the facts.
What Were the Facts of This Case?
The plaintiff, Hii Chii Kok, was a Malaysian businessman and the founder/executive chairman of a conglomerate with diversified business interests. He was also the controlling shareholder of a private education provider in Malaysia. The judgment records that he held a law degree and had worked as an English language journalist at some point in his career. His medical history included earlier treatment for hyperthyroidism and subsequent discovery of lung nodules.
Between 2002 and 2010, the plaintiff consulted various doctors in Malaysia for health issues affecting his lungs, thyroid, and prostate. In 2000, he underwent surgery for hyperthyroidism. In 2003, nodules were discovered in his lungs. Around 23 November 2006, he experienced pain in his left shoulder and underwent a chest x-ray at Sime Darby Medical Centre (“SDMC”) in Selangor, Malaysia. The x-ray showed an oval-shaped solid 12mm nodule in the lateral segment of the right middle lobe of the lung. Over time, the lung nodule grew to 18mm by 17 June 2010. A CT-guided biopsy performed on 8 July 2010 identified the lung nodule as a neuroendocrine tumour of low grade malignancy (“the lung NET”).
On 13 July 2010, the plaintiff consulted Dr Foo Yoke Ching, a medical oncologist at SDMC, about treatment for the lung NET. Dr Foo YC diagnosed him with neuroendocrine carcinoma of the right lung and considered it advisable for him to undergo a Gallium scan in Singapore to further investigate his condition. She referred him to Dr Koo Wen Hsin, a medical oncologist at NCCS, and indicated that the plaintiff was keen to have surgery in Singapore. This referral set the stage for the diagnostic pathway that later became the subject of the negligence claim.
On 19 July 2010, the plaintiff underwent a positron emission tomography (“PET”) scan using Gallium-68 tagged with DOTATATE combined with CT (“Gallium PET/CT”), performed by Dr Andrew Tan, a nuclear medicine physician at Singapore General Hospital. The scan showed very minimal tracer uptake in the right lung nodule (SUVmax 0.8), other sub-centimetre lung nodules without significant tracer uptake, and—critically—focal areas of increased tracer uptake in the pancreatic uncinate process (SUVmax 23.0) and in the pancreatic body (SUVmax 13.2), without a definite corresponding mass on imaging. The scan also showed mildly increased tracer uptake in the thyroid parenchyma, which could be secondary to hyperplasia, and physiological uptake in other organs.
The plaintiff requested advice on the scan results. Dr Tan informed him that the increased tracer uptake in the pancreatic lesions could suggest PNETs. However, because no definite mass was seen, Dr Tan advised further investigation with a contrast-enhanced CT scan or MRI. The plaintiff promptly underwent an MRI scan the next day, which revealed no mass in the pancreatic lesions. The plaintiff then saw Dr Foo YC on 21 July 2010 to update her on the Gallium PET/CT and MRI results. The case was then to be discussed at NCCS’s Tumour Board, a multidisciplinary forum for complex medical issues, to determine diagnosis and treatment options.
What Were the Key Legal Issues?
The central legal issues were whether the defendants breached their duty of care in (a) diagnosing the plaintiff’s condition and (b) advising him regarding treatment options and risks, and whether any such breach caused the plaintiff’s loss. The plaintiff’s claim was not simply that the post-operative diagnosis turned out to be hyperplasia rather than PNETs; rather, it was framed as negligence in the diagnostic process and in the advice and post-operative management that followed.
A further issue concerned the applicable legal test for medical negligence in Singapore, particularly in relation to advice and informed consent. The High Court noted that Singapore law follows the Bolam–Bolitho test as set out in Khoo James v Gunapathy, which applies to questions of diagnosis and treatment. The plaintiff’s case raised the argument—previously considered in other High Court decisions—that the doctrine of informed consent should apply instead of Bolam–Bolitho when assessing whether a doctor was negligent in advice about material risks and alternative treatments.
Finally, the court had to consider whether, even if it were to adopt the more patient-centric informed consent approach associated with Montgomery v Lanarkshire Health Board (as the UK Supreme Court had done), the defendants would still be found to have taken reasonable care to ensure the plaintiff was aware of material risks and reasonable alternatives. This issue mattered because the plaintiff’s complaint was closely tied to the decision to proceed with surgery despite diagnostic uncertainty.
How Did the Court Analyse the Issues?
The court began by situating the case within Singapore’s medical negligence framework. It referred to Khoo James and another v Gunapathy d/o Muniandy and another appeal [2002] 1 SLR(R) 1024, which sets out the approach to negligence in medical cases. The High Court emphasised that Singapore currently follows the Bolam–Bolitho test, derived from Bolam v Friern Hospital Management Committee and supplemented by Bolitho v City and Hackney Health Authority. Under this framework, the question is whether the doctor’s conduct accorded with a practice accepted as proper by a responsible body of medical opinion, and whether that opinion is defensible (Bolitho’s requirement that the professional opinion must withstand logical scrutiny).
The court then addressed the plaintiff’s attempt to shift the analysis from Bolam–Bolitho to informed consent principles. It noted that the High Court had previously considered arguments that informed consent should govern advice about material risks and alternative treatment options. In Surender Singh v Li Man Kay and others [2010] 1 SLR 428, D’Conceicao Jeanie Doris v Tong Ming Chuan [2011] SGHC 193, and Tong Seok May Joanne v Yau Hok Man Gordon [2013] 2 SLR 18, the High Court had observed that it was bound by Khoo James to apply Bolam–Bolitho in relation to medical advice. The present judge adopted a similar view, holding that he was obliged to apply Bolam–Bolitho to the question of medical advice as well.
At the same time, the court engaged in a comparative analysis. It observed that English law had moved away from Bolam–Bolitho and adopted the informed consent doctrine in Montgomery v Lanarkshire Health Board (General Medical Council intervening) [2015] AC 1430. Montgomery was described as a shift away from medical paternalism towards a patient-centric approach. The judgment also referenced philosophical justifications for each approach, contrasting a dialogue-based model of physician-patient communication with a more cautious approach to disclosing every risk. Importantly, the court did not decide that Singapore law must follow Montgomery; rather, it stated that it remained to be decided whether Singapore should adopt that approach.
Applying the Bolam–Bolitho test, the court found that the defendants were not negligent in reaching the diagnoses and in their advice. The court accepted that the consensus among experts was that the most definitive way to distinguish PNETs from hyperplasia was post-operative histopathology. It further found that there was no diagnostic tool or investigative procedure capable of differentiating between the two conditions pre-operatively. This factual finding was crucial: it meant that diagnostic uncertainty was inherent in the medical problem, not the result of a negligent failure to investigate.
On the advice dimension, the court recorded that the defendants informed the plaintiff of both the clinical diagnosis (PNETs) and the differential diagnosis (hyperplasia), as well as the options flowing from those diagnoses. The NCCS highlighted that the plaintiff could either wait for six months or proceed with surgical resection of the pancreatic lesions. The plaintiff consulted Prof Ooi, who advised that the lesions could be removed via a Whipple procedure for the uncinate process lesion and a surgical resection for the pancreatic body lesion. The plaintiff, after considering risks and options, chose aggressive treatment and proceeded with surgery.
The court then addressed the plaintiff’s complaint that the post-operative histopathology ultimately showed hyperplasia rather than PNETs. The court treated this outcome as insufficient, by itself, to establish negligence. The key question was whether the defendants acted in accordance with responsible medical practice at the time, given the available information and the known limitations of pre-operative diagnostics. Since experts agreed that histopathology was the definitive differentiator and no pre-operative tool could reliably distinguish the conditions, the court concluded that the defendants’ diagnostic and advisory steps were reasonable and non-negligent.
Finally, the court considered the alternative informed consent approach. Even if Montgomery were applied, the court held that the defendants had not been negligent. This conclusion rested on the finding that the plaintiff was made aware of the diagnoses, the differential diagnosis, and the treatment options, including the alternative of waiting. The court’s reasoning indicates that the defendants took reasonable care to ensure the plaintiff understood the material uncertainty and the reasonable alternatives, satisfying the core concerns that Montgomery sought to address.
What Was the Outcome?
The High Court dismissed the plaintiff’s claim. It held that the defendants were not negligent in reaching the diagnoses, in advising the plaintiff, or in the post-operative management. The court’s findings emphasised that the medical team acted within the bounds of responsible professional practice and that the diagnostic uncertainty between PNETs and hyperplasia was not something that pre-operative testing could reliably resolve.
Practically, the decision confirms that where a condition cannot be definitively distinguished pre-operatively and the medical team discloses the relevant diagnostic possibilities and options, a later “wrong” diagnosis (in the sense of the ultimate histopathological finding) does not automatically establish breach of duty or causation in negligence.
Why Does This Case Matter?
This case is significant for practitioners because it reinforces Singapore’s current approach to medical negligence: the Bolam–Bolitho test remains the governing framework, including in relation to medical advice, because the High Court is bound by Khoo James. The judgment also illustrates how Singapore courts engage with developments in other jurisdictions (notably Montgomery) without necessarily adopting them. For litigators, this means that arguments for an informed consent standard must confront the binding nature of Khoo James and the High Court’s stated obligation to apply Bolam–Bolitho.
Substantively, the decision is also useful for assessing causation and breach where diagnostic uncertainty is inherent. The court’s reliance on expert consensus that histopathology was the definitive method, and that no pre-operative tool could reliably differentiate PNETs from hyperplasia, provides a template for how courts may evaluate whether a clinician’s diagnostic pathway was reasonable. It suggests that courts will focus on the reasonableness of the process and disclosure of uncertainty, rather than outcome determinism.
For healthcare providers, the case underscores the importance of documenting and communicating differential diagnoses and treatment options, including reasonable alternatives (such as waiting versus surgery). For patients and claimants, it highlights the evidential challenge of proving negligence where the medical literature and expert evidence show that the definitive diagnosis requires post-operative histology and where the clinician has already disclosed the relevant possibilities.
Legislation Referenced
- Not stated in the provided extract.
Cases Cited
- [2011] SGHC 193
- [2016] SGHC 21
- Khoo James and another v Gunapathy d/o Muniandy and another appeal [2002] 1 SLR(R) 1024
- Bolam v Friern Hospital Management Committee [1957] 1 WLR 582
- Bolitho v City and Hackney Health Authority [1998] AC 232
- Surender Singh s/o Jagdish Singh and another (administrators of the estate of Narindar Kaur d/o Sarwan Singh, deceased) v Li Man Kay and others [2010] 1 SLR 428
- D’Conceicao Jeanie Doris (administratrix of the estate of Milakov Steven, deceased) v Tong Ming Chuan [2011] SGHC 193
- Tong Seok May Joanne v Yau Hok Man Gordon [2013] 2 SLR 18
- Montgomery v Lanarkshire Health Board (General Medical Council intervening) [2015] AC 1430
- [2017] SGCA 38
Source Documents
This article analyses [2016] SGHC 21 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.